美股詳情

本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

CG Oncology Inc.

39.82

-0.0350-0.09%

盤後：39.820.00000.00%19:30 EDT

成交量：56.05萬

成交額：2,228.79萬

市值：30.36億

市盈率：-22.44

高：40.27

開：40.19

低：39.15

收：39.86

52周最高：40.65

52周最低：14.80

股本：7,624.76萬

流通股本：6,127.99萬

量比：0.62

換手率：0.91%

股息：- -

股息率：- -

每股收益(TTM):-1.7747

每股收益(LYR):-1.4087

淨資產收益率：-16.57%

總資產收益率：-12.85%

市淨率：4.53

市盈率(LYR):-28.27

資料載入中...

總覽公司新聞公告

Cg Oncology, Inc.盤中異動股價大漲5.01%報39.42美元

美國研究綜述-Carmax、Mirion Technologies、Valmont Industries

美國研究綜述-Carmax、Mirion Technologies、Valmont Industries

CG Oncology在Bond-003隊列C研究中持續展現卓越疾病控制持久性和耐受性；24個月時新增12名患者達到完全緩解

高盛最新研報以「2Q25 EPS更新」為主題其中重點對Amylyx(AMLX.US)、CG Oncology(CGON.

Cg Oncology, Inc.盤中異動股價大漲5.02%

Cg Oncology, Inc.盤中異動快速拉昇8.83%報28.34美元

Cg Oncology, Inc.盤中異動急速下挫6.47%報25.16美元

Cg Oncology, Inc.盤中異動大幅下挫5.17%報26.99美元

Cg Oncology, Inc.盤中異動大幅上漲5.25%報27.45美元

Cg Oncology, Inc.盤中異動急速拉昇5.05%報27.27美元

大摩力薦CG Oncology(CGON.US) 其膀胱癌療法具有顯著優勢

Cg Oncology, Inc.盤中異動早盤股價大漲5.05%

Cg Oncology, Inc.盤中異動急速拉昇5.07%

Cg Oncology, Inc.盤中異動早盤大幅上漲5.19%

Cg Oncology, Inc.盤中異動大幅上漲5.15%報26.14美元

大摩：維持CG Oncology(CGON.US)評級，由增持調整至增持評級, 目標價由55.00美元調整至52.00美元。

Cg Oncology, Inc.盤中異動早盤股價大漲5.01%

Cg Oncology, Inc.盤中異動早盤股價大漲5.32%報22.86美元

Cg Oncology, Inc.盤中異動大幅下跌5.04%報26.76美元

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/CGON/news"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"CGON","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CGON\",,,,,undefined,":{"symbol":"CGON","market":"US","secType":"STK","nameCN":"CG Oncology Inc.","latestPrice":39.82,"timestamp":1759521600000,"preClose":39.855,"halted":0,"volume":560505,"hourTrading":{"tag":"盘后","latestPrice":39.82,"preClose":39.82,"latestTime":"19:30 EDT","volume":12372,"amount":492669.25,"timestamp":1759534205050},"delay":0,"floatShares":61279875,"shares":76247581,"eps":-1.774667,"marketStatus":"休市中","change":-0.035,"latestTime":"10-03 16:00:00 EDT","open":40.19,"high":40.265,"low":39.15,"amount":22287870.37455,"amplitude":0.027976,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.774667,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1759737600000},"marketStatusCode":7,"adr":0,"listingDate":1706158800000,"exchange":"NASDAQ","adjPreClose":39.855,"preHourTrading":{"tag":"盘前","latestPrice":40.15,"preClose":39.855,"latestTime":"08:40 EDT","volume":179,"amount":7134.780332,"timestamp":1759495217816},"postHourTrading":{"tag":"盘后","latestPrice":39.82,"preClose":39.82,"latestTime":"19:30 EDT","volume":12372,"amount":492669.25,"timestamp":1759534205050},"volumeRatio":0.6206345586483574,"impliedVol":0.2179,"impliedVolPercentile":0.036},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CGON\",,,,,undefined,":{"symbol":"CGON","floatShares":61279875,"roa":"-12.85%","roe":"-16.57%","lyrEps":-1.408697,"volumeRatio":0.6206345586483574,"shares":76247581,"dividePrice":0,"high":40.265,"amplitude":0.027976,"preClose":39.855,"low":39.15,"week52Low":14.8,"pbRate":"4.53","psRate":"5510.31","week52High":40.65,"institutionHeld":0,"latestPrice":39.82,"eps":-1.774667,"divideRate":0,"volume":560505,"delay":0,"ttmEps":-1.774667,"open":40.19,"prevYearClose":28.68,"prevWeekClose":37.54,"prevMonthClose":40.28,"prevQuarterClose":40.28,"fiveDayClose":37.54,"twentyDayClose":33.07,"sixtyDayClose":27.11},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/CGON\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-08-08","symbol":"CGON","fiscalQuarterEnding":"2025/06","expectedEps":-0.49,"name":null,"time":"盤前","type":"earning","dateTimestamp":1754625600000,"reportTimeType":"pre","actualEps":-0.54},{"market":"US","date":"2025-05-13","symbol":"CGON","fiscalQuarterEnding":"2025/03","expectedEps":-0.39,"name":null,"time":"盤前","type":"earning","dateTimestamp":1747108800000,"reportTimeType":"pre","actualEps":-0.45},{"market":"US","date":"2025-03-28","symbol":"CGON","fiscalQuarterEnding":"2024/12","expectedEps":-0.41,"name":null,"time":"盤前","type":"earning","dateTimestamp":1743134400000,"reportTimeType":"pre","actualEps":-0.48},{"market":"US","date":"2024-11-12","symbol":"CGON","fiscalQuarterEnding":"2024/09","expectedEps":-0.42,"name":null,"time":"盤前","type":"earning","dateTimestamp":1731387600000,"reportTimeType":"pre","actualEps":-0.3}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"CGON\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"CGON\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.0833,"buy":0.9167,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.9167,"analysts":12,"updateTime":1757390400000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/CGON\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"CGON","date":"2025-10-03","current":-22.438012,"percent":0.693827,"low":-77.942097,"twenty":-44.665332,"median":-31.426132,"eighty":-19.253545,"high":-13.496527,"avg":-34.698188,"sd":15.289123,"marketCap":3038847340},"quantilePoints":[{"date":"2024-01-26","current":-62.124194,"twenty":-62.124194,"median":-62.124194,"eighty":-62.124194,"marketCap":2539823423},{"date":"2024-02-02","current":-61.712969,"twenty":-61.712969,"median":-60.379514,"eighty":-59.355029,"marketCap":2523011292},{"date":"2024-02-09","current":-63.452965,"twenty":-62.124194,"median":-60.590915,"eighty":-59.355029,"marketCap":2594147579},{"date":"2024-02-16","current":-77.177799,"twenty":-70.608092,"median":-61.918582,"eighty":-60.168112,"marketCap":3155259972},{"date":"2024-02-23","current":-75.080046,"twenty":-72.448911,"median":-64.672589,"eighty":-60.20714,"marketCap":3069497532},{"date":"2024-03-01","current":-72.705845,"twenty":-73.870179,"median":-70.608092,"eighty":-60.516111,"marketCap":2972433066},{"date":"2024-03-08","current":-64.818944,"twenty":-72.891228,"median":-69.827533,"eighty":-60.799064,"marketCap":2649992888},{"date":"2024-03-15","current":-60.493345,"twenty":-72.302556,"median":-67.469593,"eighty":-60.20714,"marketCap":2473149409},{"date":"2024-03-22","current":-66.867912,"twenty":-72.162706,"median":-65.355579,"eighty":-60.438055,"marketCap":2733760852},{"date":"2024-03-28","current":-56.207672,"twenty":-71.967566,"median":-64.762028,"eighty":-59.842879,"marketCap":2732086332},{"date":"2024-04-05","current":-51.752186,"twenty":-71.648838,"median":-63.50175,"eighty":-58.14191,"marketCap":2515518513},{"date":"2024-04-12","current":-54.631116,"twenty":-71.284577,"median":-62.382039,"eighty":-56.136384,"marketCap":2655454642},{"date":"2024-04-19","current":-48.420853,"twenty":-71.001624,"median":-61.712969,"eighty":-54.576279,"marketCap":2353592420},{"date":"2024-04-26","current":-49.627262,"twenty":-70.73168,"median":-60.54213,"eighty":-53.208102,"marketCap":2412232322},{"date":"2024-05-03","current":-54.151294,"twenty":-70.286112,"median":-60.183337,"eighty":-53.600185,"marketCap":2632131954},{"date":"2024-05-10","current":-35.176138,"twenty":-69.778748,"median":-59.371617,"eighty":-52.278619,"marketCap":2000537303},{"date":"2024-05-17","current":-36.289307,"twenty":-68.393255,"median":-58.232975,"eighty":-49.860318,"marketCap":2063845445},{"date":"2024-05-24","current":-35.140985,"twenty":-67.52163,"median":-57.330453,"eighty":-49.032283,"marketCap":1998538098},{"date":"2024-05-31","current":-40.179539,"twenty":-67.228921,"median":-56.207672,"eighty":-47.173317,"marketCap":2285090743},{"date":"2024-06-07","current":-40.894311,"twenty":-66.477632,"median":-55.878652,"eighty":-42.192617,"marketCap":2325741235},{"date":"2024-06-14","current":-40.788853,"twenty":-65.885708,"median":-55.522213,"eighty":-41.278647,"marketCap":2319743621},{"date":"2024-06-21","current":-37.625109,"twenty":-65.85969,"median":-54.631116,"eighty":-40.788853,"marketCap":2139815216},{"date":"2024-06-28","current":-35.445642,"twenty":-65.443392,"median":-54.494024,"eighty":-40.683395,"marketCap":2015864537},{"date":"2024-07-05","current":-36.125261,"twenty":-64.796178,"median":-54.151294,"eighty":-39.560851,"marketCap":2054515824},{"date":"2024-07-12","current":-40.378738,"twenty":-64.675841,"median":-53.136814,"eighty":-38.206301,"marketCap":2296419569},{"date":"2024-07-15","current":-41.491907,"twenty":-64.64657,"median":-52.780375,"eighty":-38.236766,"marketCap":2359727711},{"date":"2024-08-02","current":-39.652248,"twenty":-64.6173,"median":-52.752957,"eighty":-38.267232,"marketCap":2255102676},{"date":"2024-08-09","current":-38.949194,"twenty":-63.924553,"median":-51.752186,"eighty":-38.000071,"marketCap":2215118586},{"date":"2024-08-16","current":-40.572681,"twenty":-63.472479,"median":-49.956283,"eighty":-38.105529,"marketCap":2307449488},{"date":"2024-08-23","current":-42.377221,"twenty":-62.965116,"median":-49.723226,"eighty":-38.189896,"marketCap":2410077328},{"date":"2024-08-30","current":-43.2618,"twenty":-62.33047,"median":-48.934948,"eighty":-38.276606,"marketCap":2460385093},{"date":"2024-09-06","current":-44.299706,"twenty":-62.063778,"median":-48.270052,"eighty":-38.375033,"marketCap":2519412871},{"date":"2024-09-13","current":-41.079839,"twenty":-61.869081,"median":-45.980618,"eighty":-38.588613,"marketCap":2336292606},{"date":"2024-09-20","current":-46.127835,"twenty":-61.368222,"median":-44.806865,"eighty":-38.861791,"marketCap":2623382252},{"date":"2024-09-27","current":-43.379744,"twenty":-60.747027,"median":-44.736098,"eighty":-39.046612,"marketCap":2467092795},{"date":"2024-10-04","current":-42.412604,"twenty":-60.551887,"median":-44.517902,"eighty":-39.324835,"marketCap":2412089639},{"date":"2024-10-11","current":-40.667036,"twenty":-60.382766,"median":-44.458898,"eighty":-39.52313,"marketCap":2312815649},{"date":"2024-10-18","current":-43.356155,"twenty":-60.203473,"median":-44.063818,"eighty":-39.574912,"marketCap":2465751255},{"date":"2024-10-25","current":-42.990529,"twenty":-60.177247,"median":-43.698192,"eighty":-39.657154,"marketCap":2444957379},{"date":"2024-10-31","current":-42.837202,"twenty":-60.01213,"median":-43.662809,"eighty":-39.673778,"marketCap":2436237366},{"date":"2024-11-08","current":-46.068863,"twenty":-59.381569,"median":-43.651015,"eighty":-39.804577,"marketCap":2620028401},{"date":"2024-11-15","current":-32.980568,"twenty":-59.208121,"median":-43.63922,"eighty":-39.654701,"marketCap":2400853462},{"date":"2024-11-22","current":-30.044833,"twenty":-58.542987,"median":-43.538968,"eighty":-38.997903,"marketCap":2187143689},{"date":"2024-11-29","current":-32.283796,"twenty":-58.232975,"median":-43.444613,"eighty":-38.328163,"marketCap":2350131206},{"date":"2024-12-06","current":-31.17825,"twenty":-58.005312,"median":-43.379744,"eighty":-38.000071,"marketCap":2269651893},{"date":"2024-12-13","current":-26.821099,"twenty":-57.745125,"median":-43.279491,"eighty":-37.543086,"marketCap":1952468717},{"date":"2024-12-20","current":-26.031423,"twenty":-56.915781,"median":-43.120267,"eighty":-36.394765,"marketCap":1894983493},{"date":"2024-12-27","current":-27.044066,"twenty":-56.349294,"median":-43.061296,"eighty":-36.125261,"marketCap":1968699839},{"date":"2025-01-03","current":-26.914002,"twenty":-56.207672,"median":-43.037707,"eighty":-35.33784,"marketCap":1959231684},{"date":"2025-01-10","current":-28.298257,"twenty":-56.136384,"median":-42.978735,"eighty":-34.953504,"marketCap":2059999900},{"date":"2025-01-17","current":-27.034776,"twenty":-55.969133,"median":-42.872585,"eighty":-33.374909,"marketCap":1968023542},{"date":"2025-01-24","current":-32.158189,"twenty":-55.840266,"median":-42.689773,"eighty":-32.852839,"marketCap":2340987506},{"date":"2025-01-31","current":-31.530712,"twenty":-55.653821,"median":-42.565931,"eighty":-32.283796,"marketCap":2295309701},{"date":"2025-02-07","current":-31.405216,"twenty":-55.437216,"median":-42.394913,"eighty":-32.036945,"marketCap":2286174140},{"date":"2025-02-14","current":-29.805151,"twenty":-55.004006,"median":-42.206678,"eighty":-31.677123,"marketCap":2169695737},{"date":"2025-02-21","current":-29.512328,"twenty":-54.631116,"median":-41.999801,"eighty":-31.530712,"marketCap":2148379428},{"date":"2025-02-28","current":-25.768383,"twenty":-54.494024,"median":-41.775708,"eighty":-31.373843,"marketCap":1875835192},{"date":"2025-03-07","current":-28.226,"twenty":-54.39406,"median":-41.609082,"eighty":-31.094637,"marketCap":2054739928},{"date":"2025-03-14","current":-27.138374,"twenty":-54.151294,"median":-41.292708,"eighty":-30.560445,"marketCap":1975565066},{"date":"2025-03-21","current":-29.020804,"twenty":-53.671473,"median":-41.068045,"eighty":-30.21301,"marketCap":2112598481},{"date":"2025-03-28","current":-28.173711,"twenty":-53.493253,"median":-40.922206,"eighty":-29.826066,"marketCap":2050933444},{"date":"2025-04-04","current":-16.223536,"twenty":-52.780375,"median":-40.788853,"eighty":-29.478125,"marketCap":1428303862},{"date":"2025-04-11","current":-15.26259,"twenty":-52.725539,"median":-40.592885,"eighty":-29.073094,"marketCap":1343703153},{"date":"2025-04-17","current":-17.504797,"twenty":-52.648767,"median":-40.36956,"eighty":-28.807616,"marketCap":1541104808},{"date":"2025-04-25","current":-18.630229,"twenty":-51.927664,"median":-39.710836,"eighty":-28.715432,"marketCap":1640186719},{"date":"2025-05-02","current":-24.014988,"twenty":-51.631545,"median":-39.587801,"eighty":-28.276198,"marketCap":2114255557},{"date":"2025-05-09","current":-20.891121,"twenty":-50.318205,"median":-39.192738,"eighty":-28.046644,"marketCap":1839233409},{"date":"2025-05-16","current":-18.305859,"twenty":-49.931606,"median":-38.624431,"eighty":-27.822323,"marketCap":1932311557},{"date":"2025-05-23","current":-18.60193,"twenty":-49.805481,"median":-38.19927,"eighty":-27.481395,"marketCap":1963563934},{"date":"2025-05-30","current":-18.941329,"twenty":-49.745161,"median":-38.000071,"eighty":-27.137812,"marketCap":1999389828},{"date":"2025-06-06","current":-19.230179,"twenty":-49.665648,"median":-37.795014,"eighty":-26.986466,"marketCap":2029879952},{"date":"2025-06-13","current":-19.136302,"twenty":-49.503879,"median":-37.543086,"eighty":-26.644583,"marketCap":2019970662},{"date":"2025-06-20","current":-18.977435,"twenty":-49.032283,"median":-37.168124,"eighty":-26.449487,"marketCap":2003201094},{"date":"2025-06-27","current":-18.825789,"twenty":-48.437304,"median":-36.365471,"eighty":-26.243173,"marketCap":1987193779},{"date":"2025-07-03","current":-19.425152,"twenty":-48.360533,"median":-36.207284,"eighty":-25.994262,"marketCap":2050460785},{"date":"2025-07-11","current":-19.576798,"twenty":-47.916755,"median":-36.101826,"eighty":-24.54782,"marketCap":2066468099},{"date":"2025-07-18","current":-20.551667,"twenty":-47.047797,"median":-35.158562,"eighty":-23.322415,"marketCap":2169372265},{"date":"2025-07-25","current":-18.876337,"twenty":-46.758067,"median":-34.836328,"eighty":-20.953178,"marketCap":1992529551},{"date":"2025-08-01","current":-19.273506,"twenty":-46.459723,"median":-33.67043,"eighty":-19.630235,"marketCap":2034453470},{"date":"2025-08-08","current":-17.583734,"twenty":-46.116041,"median":-33.231407,"eighty":-19.436706,"marketCap":1856086249},{"date":"2025-08-15","current":-15.454183,"twenty":-46.05471,"median":-32.738157,"eighty":-19.425152,"marketCap":1979387202},{"date":"2025-08-22","current":-15.466089,"twenty":-45.994601,"median":-32.283796,"eighty":-19.321744,"marketCap":1980912154},{"date":"2025-08-29","current":-15.90364,"twenty":-45.910989,"median":-32.179105,"eighty":-19.234852,"marketCap":2036954126},{"date":"2025-09-05","current":-18.418814,"twenty":-45.632471,"median":-32.073773,"eighty":-19.17963,"marketCap":2359100156},{"date":"2025-09-12","current":-19.740397,"twenty":-45.219668,"median":-31.708497,"eighty":-19.194072,"marketCap":2528369785},{"date":"2025-09-19","current":-23.109837,"twenty":-44.877631,"median":-31.635292,"eighty":-19.201294,"marketCap":2959931094},{"date":"2025-09-26","current":-21.716818,"twenty":-44.736098,"median":-31.530712,"eighty":-19.230179,"marketCap":2781511754},{"date":"2025-10-03","current":-23.725981,"twenty":-44.665332,"median":-31.426132,"eighty":-19.253545,"marketCap":3038847340}],"updateTime":1759684233278},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"CGON\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2571357394","title":"Cg Oncology, Inc.盤中異動 股價大漲5.01%報39.42美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2571357394","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2571357394?lang=zh_tw&edition=fundamental","pubTime":"2025-09-30 00:52","pubTimestamp":1759164725,"startTime":"0","endTime":"0","summary":"北京时间2025年09月30日00时52分，Cg Oncology, Inc.股票出现异动，股价快速拉升5.01%。截至发稿，该股报39.42美元/股，成交量20.8748万股，换手率0.27%，振幅4.64%。Cg Oncology, Inc.股票所在的生物技术行业中，整体涨幅为1.68%。Cg Oncology, Inc.公司简介：CG Oncology Inc 是一家后期临床生物制药公司，专注于为患有膀胱癌的患者开发和商业化一种潜在的骨干膀胱保留治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250930005206a44cca0b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250930005206a44cca0b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4135","CGON","BCG","BK4139"],"gpt_icon":0},{"id":"2570009184","title":"美國研究綜述-Carmax、Mirion Technologies、Valmont Industries","url":"https://stock-news.laohu8.com/highlight/detail?id=2570009184","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2570009184?lang=zh_tw&edition=fundamental","pubTime":"2025-09-26 17:41","pubTimestamp":1758879719,"startTime":"0","endTime":"0","summary":"美国研究综述-Carmax、Mirion Technologies、Valmont Industries路透社9月26日 - 华尔街证券分析师周五调整了对几家美国上市公司的评级和目标价，其中包括 Carmax、Mirion Technologies 和 Valmont Industries。* First Horizon Corp FHN.N：D.A.戴维森给予该公司中性评级* Mirion Technologies Inc MIR.N：摩根大通给予增持评级* Riot Platforms Inc RIOT.O：摩根大通将其评级从中性上调至增持* Valmont Industries Inc VMI.N：摩根大通给予该公司增持评级以下是路透社周五报道的美国公司研究行动摘要。* Allarity Therapeutics ALLR.O：Ascendiant Capital Markets将其预测价格从9美元上调至9.25美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250926:nL3S3VD0JX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0265550946.USD","DAVE","KMX","LU2290526834.HKD","BK4139","LEVI","CALM","LU0417517546.SGD","IE00B894F039.SGD","VMI","GH","RL","BK4023","BK4170","BK4202","LU0942090050.USD","IMRX","KVYO","LU1861215975.USD","LU0868494708.USD","THO","FHN","LU0965509010.AUD","ALLR","MIR","LU0980610538.SGD","BK4551","BK4504","LU2125154778.USD","SYRE","FRME","LU1934455863.HKD","BK4099","LU2468319806.SGD","ROL","LU1923622291.USD","PSTG","CGON","CRNX","MCK","LU0648001328.SGD","SNX","UTHR","LU2237438978.USD"],"gpt_icon":1},{"id":"2570009182","title":"美國研究綜述-Carmax、Mirion Technologies、Valmont Industries","url":"https://stock-news.laohu8.com/highlight/detail?id=2570009182","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2570009182?lang=zh_tw&edition=fundamental","pubTime":"2025-09-26 17:41","pubTimestamp":1758879719,"startTime":"0","endTime":"0","summary":"美国研究综述-Carmax、Mirion Technologies、Valmont Industries路透社9月26日 - 华尔街证券分析师周五调整了对几家美国上市公司的评级和目标价，其中包括 Carmax、Mirion Technologies 和 Valmont Industries。* First Horizon Corp FHN.N：D.A.戴维森给予该公司中性评级* Mirion Technologies Inc MIR.N：摩根大通给予增持评级* Riot Platforms Inc RIOT.O：摩根大通将其评级从中性上调至增持* Valmont Industries Inc VMI.N：摩根大通给予该公司增持评级以下是路透社周五报导的美国公司研究行动摘要。* Allarity Therapeutics ALLR.O：Ascendiant Capital Markets将其预测价格从9美元上调至9.25美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250926:nL3T3VD0JX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0742534661.SGD","LU2211817866.USD","LU2168564495.EUR","SYRE","LU2125909916.SGD","MCK","SNX","FRME","ROL","LU0256863811.USD","LU0417517546.SGD","MIR","LU2168563687.JPY","THO","FHN","LU0689472784.USD","LU1066051498.USD","RL","LU2089279066.USD","PSTG","BK4155","LU1066053197.SGD","LU1814569148.SGD","GH","IMRX","BK4212","UTHR","LU2125909759.SGD","IE00BLDYK493.USD","IE00B5TLWC47.USD","LU0048573561.USD","LU1201861249.SGD","DAVE","LU0648001328.SGD","LEVI","CGON","VMI","IE00B19Z9Z06.USD","CALM","KMX","LU1037948897.HKD","CRNX","KVYO","ALLR"],"gpt_icon":1},{"id":"1104742563","title":"CG Oncology在Bond-003隊列C研究中持續展現卓越疾病控制持久性和耐受性；24個月時新增12名患者達到完全緩解","url":"https://stock-news.laohu8.com/highlight/detail?id=1104742563","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1104742563?lang=zh_tw&edition=fundamental","pubTime":"2025-09-05 19:00","pubTimestamp":1757070023,"startTime":"0","endTime":"0","summary":"CG Oncology在其Bond-003队列C临床研究中继续展现出同类疾病中最佳的持久性和耐受性表现。最新数据显示，在24个月的随访期内，该研究新增12名患者达到完全缓解状态，进一步证实了治疗方案的有效性和安全性。这一积极结果为CG Oncology的肿瘤治疗管线增添了更多信心，显示出其在肿瘤免疫治疗领域的领先地位。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CGON","BK4139"],"gpt_icon":0},{"id":"2558850641","title":"高盛最新研報以「2Q25 EPS更新」為主題其中重點對Amylyx(AMLX.US)、CG Oncology(CGON.","url":"https://stock-news.laohu8.com/highlight/detail?id=2558850641","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2558850641?lang=zh_tw&edition=fundamental","pubTime":"2025-08-12 19:17","pubTimestamp":1754997464,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4585","BK4599","IE00B3QW5Z07.USD","LU0096364046.USD","LU1868837300.USD","IE0004086264.USD","BK4533","LU2237443622.USD","BK4516","LU1868836914.USD","IE0004091025.USD","LU1868837136.USD","GPCR","LU2237443549.SGD","LU2750360997.AUD","IE00B64PRP62.GBP","LU0251131958.USD","LU2750360641.GBP","IE00B19Z3B42.SGD","LU1868836757.USD","BK4550","LU2237443978.SGD","BK4552","CGON","LU2237438978.USD","LU1868836591.USD","LU2237443895.HKD","BK4139","BK4127","LU0048573561.USD","BK4135","CG","IDYA","LU0742534661.SGD","LU2237443465.HKD","IE00BFXG1179.USD","IE00B19Z3581.USD","IE00BGHQF748.EUR","LU1668664300.SGD","159399","AMLX","BK4504","LU2471134879.HKD","LU2471134952.CNY","LU2471134796.USD","LU1894683348.USD","159837","IE00BSNM7G36.USD","LU0061475181.USD"],"gpt_icon":0},{"id":"2557313418","title":"Cg Oncology, Inc.盤中異動 股價大漲5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2557313418","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2557313418?lang=zh_tw&edition=fundamental","pubTime":"2025-08-06 00:30","pubTimestamp":1754411405,"startTime":"0","endTime":"0","summary":"北京时间2025年08月06日00时30分，Cg Oncology, Inc.股票出现异动，股价急速上涨5.02%。截至发稿，该股报27.40美元/股，成交量27.8492万股，换手率0.37%，振幅5.67%。Cg Oncology, Inc.股票所在的生物技术行业中，整体跌幅为3.13%。Cg Oncology, Inc.公司简介：CG Oncology Inc 是一家后期临床生物制药公司，专注于为患有膀胱癌的患者开发和商业化一种潜在的骨干膀胱保留治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025080600300594d1a21c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025080600300594d1a21c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4135","CGON","BCG","BK4139"],"gpt_icon":0},{"id":"2555042791","title":"Cg Oncology, Inc.盤中異動 快速拉昇8.83%報28.34美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2555042791","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2555042791?lang=zh_tw&edition=fundamental","pubTime":"2025-07-30 21:31","pubTimestamp":1753882308,"startTime":"0","endTime":"0","summary":"北京时间2025年07月30日21时31分，Cg Oncology, Inc.股票出现波动，股价急速上涨8.83%。截至发稿，该股报28.34美元/股，成交量3.8003万股，换手率0.05%，振幅1.88%。Cg Oncology, Inc.股票所在的生物技术行业中，整体涨幅为0.58%。Cg Oncology, Inc.公司简介：CG Oncology Inc 是一家后期临床生物制药公司，专注于为患有膀胱癌的患者开发和商业化一种潜在的骨干膀胱保留治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250730213149a6c9d4ce&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250730213149a6c9d4ce&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BCG","BK4139","BK4135","CGON"],"gpt_icon":0},{"id":"2553259679","title":"Cg Oncology, Inc.盤中異動 急速下挫6.47%報25.16美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2553259679","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2553259679?lang=zh_tw&edition=fundamental","pubTime":"2025-07-22 21:32","pubTimestamp":1753191138,"startTime":"0","endTime":"0","summary":"北京时间2025年07月22日21时32分，Cg Oncology, Inc.股票出现异动，股价急速下跌6.47%。截至发稿，该股报25.16美元/股，成交量5.6856万股，换手率0.07%，振幅2.45%。Cg Oncology, Inc.股票所在的生物技术行业中，整体涨幅为0.25%。Cg Oncology, Inc.公司简介：CG Oncology Inc 是一家后期临床生物制药公司，专注于为患有膀胱癌的患者开发和商业化一种潜在的骨干膀胱保留治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250722213218a6bb08d3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250722213218a6bb08d3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4135","BK4139","CGON","BCG"],"gpt_icon":0},{"id":"2552592497","title":"Cg Oncology, Inc.盤中異動 大幅下挫5.17%報26.99美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2552592497","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2552592497?lang=zh_tw&edition=fundamental","pubTime":"2025-07-19 03:34","pubTimestamp":1752867251,"startTime":"0","endTime":"0","summary":"北京时间2025年07月19日03时34分，Cg Oncology, Inc.股票出现波动，股价急速下跌5.17%。截至发稿，该股报26.99美元/股，成交量76.3415万股，换手率1.00%，振幅6.01%。Cg Oncology, Inc.股票所在的生物技术行业中，整体跌幅为0.71%。Cg Oncology, Inc.公司简介：CG Oncology Inc 是一家后期临床生物制药公司，专注于为膀胱癌患者开发和商业化潜在的膀胱保留疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250719033412a6b2c153&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250719033412a6b2c153&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CGON","BK4139"],"gpt_icon":0},{"id":"2552389064","title":"Cg Oncology, Inc.盤中異動 大幅上漲5.25%報27.45美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2552389064","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2552389064?lang=zh_tw&edition=fundamental","pubTime":"2025-07-17 23:34","pubTimestamp":1752766450,"startTime":"0","endTime":"0","summary":"北京时间2025年07月17日23时34分，Cg Oncology, Inc.股票出现波动，股价大幅上涨5.25%。截至发稿，该股报27.45美元/股，成交量18.559万股，换手率0.24%，振幅6.06%。Cg Oncology, Inc.股票所在的生物技术行业中，整体涨幅为0.25%。Cg Oncology, Inc.公司简介：CG Oncology Inc 是一家后期临床生物制药公司，专注于为膀胱癌患者开发和商业化潜在的膀胱保留疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250717233411a451736d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250717233411a451736d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CGON"],"gpt_icon":0},{"id":"2550592966","title":"Cg Oncology, Inc.盤中異動 急速拉昇5.05%報27.27美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2550592966","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2550592966?lang=zh_tw&edition=fundamental","pubTime":"2025-07-09 23:05","pubTimestamp":1752073520,"startTime":"0","endTime":"0","summary":"北京时间2025年07月09日23时05分，Cg Oncology, Inc.股票出现异动，股价快速拉升5.05%。截至发稿，该股报27.27美元/股，成交量33.8952万股，换手率0.44%，振幅5.51%。Cg Oncology, Inc.股票所在的生物技术行业中，整体涨幅为1.35%。Cg Oncology, Inc.公司简介：CG Oncology Inc 是一家后期临床生物制药公司，专注于为膀胱癌患者开发和商业化潜在的膀胱保留疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709230520a69fb08b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709230520a69fb08b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CGON"],"gpt_icon":0},{"id":"2549307299","title":"大摩力薦CG Oncology(CGON.US) 其膀胱癌療法具有顯著優勢","url":"https://stock-news.laohu8.com/highlight/detail?id=2549307299","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2549307299?lang=zh_tw&edition=fundamental","pubTime":"2025-07-07 14:24","pubTimestamp":1751869467,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，摩根士丹利将制药公司CG Oncology的目标价从52美元上调至56美元，同时维持“增持”评级。据了解，CG Oncology是一家临床生物制药公司，致力于开发和商业化膀胱癌疗法。其产品cretostimogene目前处于临床开发阶段，用于治疗非肌层浸润性膀胱癌 。因此，摩根士丹利认为cretostimogene凭借其安全性和持久性数据，以及“最佳疾病治疗潜力”，具有显著的差异化优势，这支持了该行对CG Oncology的乐观看法。截至7月3日美股收盘，CG Oncology涨0.82%，报26.90美元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1314530.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4135","BK4588","LU0320765646.SGD","LU1732799900.SGD","LU0234570918.USD","IE00B3QW5Z07.USD","CG","BK4585","LU0158827948.USD","LU0314104364.USD","LU2133065610.SGD","LU0912757837.SGD","LU0006306889.USD","LU1548497426.USD","BK4516","LU1989772923.USD","BK4504","LU0158827781.USD","LU0106831901.USD","BK4534","LU2111349929.HKD","CGON","LU0098860793.USD","IE00B64PRP62.GBP","LU2347655156.SGD","LU0106261372.USD","LU0971096721.USD","LU2271345857.HKD","BK4127","LU1162221912.USD","LU1363072403.SGD","LU1720051017.SGD","LU0795875169.SGD","LU1074936037.SGD","BK4139","IE00BGHQF748.EUR","LU1720051108.HKD","LU0795875086.SGD","LU2357305700.SGD","LU1668664300.SGD","LU1989772840.SGD","LU2089284900.SGD","IE00BZ1G4Q59.USD","LU2023251221.USD","LU1732800096.USD","IE00BKVL7J92.USD","BK4581","LU0225283273.USD","LU2028103732.USD","LU0267386448.USD"],"gpt_icon":0},{"id":"2544966649","title":"Cg Oncology, Inc.盤中異動 早盤股價大漲5.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2544966649","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2544966649?lang=zh_tw&edition=fundamental","pubTime":"2025-06-17 22:24","pubTimestamp":1750170281,"startTime":"0","endTime":"0","summary":"北京时间2025年06月17日22时24分，Cg Oncology, Inc.股票出现异动，股价大幅上涨5.05%。截至发稿，该股报26.75美元/股，成交量21.3672万股，换手率0.28%，振幅4.60%。Cg Oncology, Inc.股票所在的生物技术行业中，整体跌幅为0.63%。Cg Oncology, Inc.公司简介：CG Oncology Inc 是一家后期临床生物制药公司，专注于为膀胱癌患者开发和商业化潜在的膀胱保留疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250617222441a4ae8764&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250617222441a4ae8764&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CGON","BK4139"],"gpt_icon":0},{"id":"2541586582","title":"Cg Oncology, Inc.盤中異動 急速拉昇5.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2541586582","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2541586582?lang=zh_tw&edition=fundamental","pubTime":"2025-06-06 22:02","pubTimestamp":1749218571,"startTime":"0","endTime":"0","summary":"北京时间2025年06月06日22时02分，Cg Oncology, Inc.股票出现波动，股价急速上涨5.07%。Cg Oncology, Inc.股票所在的生物技术行业中，整体涨幅为1.10%。其相关个股中，Tango Therapeutics, Inc.、Eyenovia, Inc.、Aspire Biopharma Holdings Inc C/Wts 14/02/2030 涨幅较大，Nucana Plc、Eyenovia, Inc.、Glycomimetics, Inc.较为活跃，换手率分别为2045.11%、651.48%、82.39%，振幅较大的相关个股有Tevogen Bio Holdings Inc C/Wts 14/02/2029 、Tango Therapeutics, Inc.、Eyenovia, Inc.，振幅分别为34.76%、30.65%、29.62%。Cg Oncology, Inc.公司简介：CG Oncology Inc 是一家后期临床生物制药公司，专注于为膀胱癌患者开发和商业化潜在的膀胱保留疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250606220251a49d04e9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250606220251a49d04e9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CGON"],"gpt_icon":0},{"id":"2540795496","title":"Cg Oncology, Inc.盤中異動 早盤大幅上漲5.19%","url":"https://stock-news.laohu8.com/highlight/detail?id=2540795496","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540795496?lang=zh_tw&edition=fundamental","pubTime":"2025-06-02 21:38","pubTimestamp":1748871499,"startTime":"0","endTime":"0","summary":"北京时间2025年06月02日21时38分，Cg Oncology, Inc.股票出现波动，股价快速拉升5.19%。截至发稿，该股报26.95美元/股，成交量2.2261万股，换手率0.03%，振幅4.06%。Cg Oncology, Inc.股票所在的生物技术行业中，整体涨幅为0.99%。Cg Oncology, Inc.公司简介：CG Oncology Inc 是一家后期临床生物制药公司，专注于为膀胱癌患者开发和商业化潜在的膀胱保留疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250602213819a6f72561&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250602213819a6f72561&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CGON"],"gpt_icon":0},{"id":"2537135647","title":"Cg Oncology, Inc.盤中異動 大幅上漲5.15%報26.14美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2537135647","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537135647?lang=zh_tw&edition=fundamental","pubTime":"2025-05-21 02:00","pubTimestamp":1747764046,"startTime":"0","endTime":"0","summary":"北京时间2025年05月21日02时00分，Cg Oncology, Inc.股票出现异动，股价大幅拉升5.15%。截至发稿，该股报26.14美元/股，成交量56.7502万股，换手率0.74%，振幅5.73%。Cg Oncology, Inc.股票所在的生物技术行业中，整体涨幅为0.76%。Cg Oncology, Inc.公司简介：CG Oncology Inc 是一家后期临床生物制药公司，专注于为膀胱癌患者开发和商业化潜在的膀胱保留疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250521020046a6e658f6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250521020046a6e658f6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4082","NRXS","CGON"],"gpt_icon":0},{"id":"2536333296","title":"大摩：維持CG Oncology(CGON.US)評級，由增持調整至增持評級, 目標價由55.00美元調整至52.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2536333296","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2536333296?lang=zh_tw&edition=fundamental","pubTime":"2025-05-19 22:42","pubTimestamp":1747665775,"startTime":"0","endTime":"0","summary":"大摩：维持CG Oncology(CGON.US)评级，由增持调整至增持评级, 目标价由55.00美元调整至52.00美元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/05/19224250511683.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["CGON","CG"],"gpt_icon":0},{"id":"2533329661","title":"Cg Oncology, Inc.盤中異動 早盤股價大漲5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2533329661","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533329661?lang=zh_tw&edition=fundamental","pubTime":"2025-05-08 22:44","pubTimestamp":1746715474,"startTime":"0","endTime":"0","summary":"北京时间2025年05月08日22时44分，Cg Oncology, Inc.股票出现波动，股价快速上涨5.01%。截至发稿，该股报23.46美元/股，成交量48.0018万股，换手率0.63%，振幅6.65%。Cg Oncology, Inc.股票所在的生物技术行业中，整体跌幅为3.15%。Cg Oncology, Inc.公司简介：CG Oncology Inc 是一家后期临床生物制药公司，专注于为膀胱癌患者开发和商业化潜在的膀胱保留疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250508224434aa2c8796&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250508224434aa2c8796&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CGON"],"gpt_icon":0},{"id":"2533931788","title":"Cg Oncology, Inc.盤中異動 早盤股價大漲5.32%報22.86美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2533931788","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533931788?lang=zh_tw&edition=fundamental","pubTime":"2025-05-07 21:31","pubTimestamp":1746624662,"startTime":"0","endTime":"0","summary":"北京时间2025年05月07日21时31分，Cg Oncology, Inc.股票出现波动，股价急速上涨5.32%。截至发稿，该股报22.86美元/股，成交量2.6633万股，换手率0.03%，振幅0.55%。Cg Oncology, Inc.股票所在的生物技术行业中，整体涨幅为0.09%。Cg Oncology, Inc.公司简介：CG Oncology Inc 是一家后期临床生物制药公司，专注于为膀胱癌患者开发和商业化潜在的膀胱保留疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250507213102a4756df3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250507213102a4756df3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CGON"],"gpt_icon":0},{"id":"2533650561","title":"Cg Oncology, Inc.盤中異動 大幅下跌5.04%報26.76美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2533650561","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533650561?lang=zh_tw&edition=fundamental","pubTime":"2025-05-07 00:44","pubTimestamp":1746549887,"startTime":"0","endTime":"0","summary":"北京时间2025年05月07日00时44分，Cg Oncology, Inc.股票出现异动，股价急速跳水5.04%。截至发稿，该股报26.76美元/股，成交量32.2668万股，换手率0.42%，振幅5.80%。Cg Oncology, Inc.股票所在的生物技术行业中，整体跌幅为5.33%。Cg Oncology, Inc.公司简介：CG Oncology Inc 是一家后期临床生物制药公司，专注于为膀胱癌患者开发和商业化潜在的膀胱保留疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250507004447a4744145&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250507004447a4744145&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CGON"],"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":33,"code":"91000000","status":"200"}]}}